ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).

MLA

Rautureau, Yohann, et al. “ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).” Circulation, vol. 138, no. 16, Oct. 2018, pp. 1677–92. EBSCOhost, https://doi.org/10.1161/CIRCULATIONAHA.117.031134.

APA

Rautureau, Y., Deschambault, V., Higgins, M.-È., Rivas, D., Mecteau, M., Geoffroy, P., Miquel, G., Uy, K., Sanchez, R., Lavoie, V., Brand, G., Nault, A., Williams, P.-M., Suarez, M. L., Merlet, N., Lapointe, L., Duquette, N., Gillis, M.-A., Samami, S., … Tardif, J.-C. (2018). ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein). Circulation, 138(16), 1677–1692. https://doi.org/10.1161/CIRCULATIONAHA.117.031134

Chicago

Rautureau, Yohann, Vanessa Deschambault, Marie-Ève Higgins, Daniel Rivas, Mélanie Mecteau, Pascale Geoffroy, Géraldine Miquel, et al. 2018. “ADCY9 (Adenylate Cyclase Type 9) Inactivation Protects From Atherosclerosis Only in the Absence of CETP (Cholesteryl Ester Transfer Protein).” Circulation 138 (16): 1677–92. doi:10.1161/CIRCULATIONAHA.117.031134.